Skip to main content
Premium Trial:

Request an Annual Quote

New Cell-Based Screening Company Launches in Pittsburgh

NEW YORK, June 15 (GenomeWeb News) - Lansing Taylor, co-founder of Cellomics and the Pittsburgh Life Sciences Greenhouse, has founded a new company, Cellumen, the company said yesterday in its maiden announcement.


Cellumen, will initially will be headquarted at the PLSG's incubator and will form drug discovery collaborations with pharmaceutical and biotechnology companies using High-Content Screening, a cell-based screening method developed by Cellomics.


Taylor joined with Alan Waggoner from Carnegie Mellon University, who has had a hand in creating other life sciences technologies with Taylor. Taylor and Kenneth Giuliano, a scientist, will be Cellumen's first two employees. The company expects to have a total staff of five to six employees by the end of its first year of operation.


The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.